The system consists of a console, disposable circuit and disposable venous catheter that can be placed in either a central or peripheral location. Ultrafiltration with the system can be provided to patients in multiple treatment venues, said the company.

Nick Mendez, president of Acute Business unit at Gambro, said: “Gambro and CHF share a common dedication to pioneering life-saving therapies for patients. This acquisition will enable Gambro to accelerate the adoption of ultrafiltration for fluid overload, thereby expanding our product offerings and providing a broader spectrum of care to patients. CHF brings a proven therapy, superior clinical results and established relationships with physicians.”

David Springer, president and CEO of CHF Solutions, said: “We are pleased to become part of a company that shares our commitment to improving patient outcomes through innovative technologies. We look forward, with Gambro’s support, to continuing to expand access to ultrafiltration therapy for many more patients.”